BSD Medical Corp. Announces Hyperthermia Therapy for Cancer a Key Topic of Discussion At ESTRO Symposia in Goteborg, Sweden
October 06, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Oct. 6, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today announced that the European Society for Therapeutic Radiation and Oncology (ESTRO) recently held in Goteborg,...
BSD Medical Participates in ASTRO, SROA and RRS Conferences
October 01, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Oct. 1, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on the company's attendance and exhibitions at both the ASTRO (American Society for Therapeutic...
Cancer Centers in Poland Purchase Seventh and Eighth New Hyperthermia Cancer Treatment System From BSD Medical
September 30, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Sept. 30, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today announced the purchase of two new BSD-500 hyperthermia cancer therapy systems in Poland from the Holy Cross...
BSD Medical Corp. Announces ESMO Recommends Hyperthermia as 'Standard Therapy' for Soft Tissue Sarcoma
September 23, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Sept. 23, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that the addition of hyperthermia to chemotherapy was recommended as standard therapy for soft tissue...
BSD Medical to Attend and Exhibit At the 50th Annual ASTRO Conference
September 18, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Sept. 18, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) announced today that it will attend and have an exhibit at the 50th ASTRO (American Society for Therapeutic Radiology...
Current Opinion in Oncology Highlights Strong Success From Use of the BSD-2000 in Treating Soft Tissue Sarcomas
September 15, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Sept. 15, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that a new article in Current Option in Oncology (see 2008, 20:pages 438-443) highlights strong...
Photo Release -- BSD Medical Receives FDA Clearance to Market the MicroThermX-100 Microwave Ablation System
September 11, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Sept. 11, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM), a leading developer of microwave systems that are used primarily in the treatment of cancer, announced today...
BSD Medical to Collaborate With General Electric On New MRI-Monitored Cancer Treatment System
August 28, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Aug. 28, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the company has agreed to collaborate with GE Medical Systems in the integration of BSD...
BSD Medical's High-End Cancer Treatment System Performs With Excellence in Adverse Environments
August 20, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Aug. 20, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that a report of two case studies has been published in the current issue of the International...
BSD Medical Provides to FDA Data Requested Regarding 510(k) Premarket Notification for MicroThermX-100 Microwave Ablation System
August 14, 2008 08:05 ET
|
BSD Medical Corporation
SALT LAKE CITY, Aug. 14, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the company has provided to the Food and Drug Administration (FDA) additional data...